Parameter | Study group (n = 150) | Control group (n = 50) | P-value |
---|---|---|---|
ABI | 0.92 ± 0.08 | 0.94 ± 0.05 | 0.175 |
Normal 1.0–1.3 (%) | 42 (27.8) | 16 (10.6) | 0.589 |
Borderline 0.9–0.99 (%) | 86 (57.0) | 31 (20.5) | 0.562 |
PAD < 0.90 (%) | 22 (14.6) | 3 (2.0) | 0.108 |
TC (mmol/L) | 4.65 ± 0.68 | 4.61 ± 0.98 | 0.453 |
TG (mmol/L) | 2.27 ± 0.21 | 2.20 ± 0.14 | 0.001* |
HDL-C (mmol/L) | 1.12 ± 0.08 | 1.19 ± 0.07 | 0.001* |
LDL-C (mmol/L) | 2.51 ± 0.70 | 2.42 ± 0.94 | 0.236 |
FPG (mmol/L) | 4.51 ± 0.80 | 4.14 ± 0.68 | 0.001* |
Family history of CVD (%) | 13 (8.6) | 20 (13.2) | 0.355 |
Diabetes (%) | 6 (4.0) | 1 (2.0) | 0.505 |
Hypertension (%) | 24 (15.9) | 5 (3.3) | 0.297 |
Metabolic syndrome (%) | 26 (17.3) | 5 (10.0) | 0.215 |